Targeted Cancer Imaging: Design and Synthesis of Nanoplatforms based on Tumor Biology
Autor Mehdi Azizi, Hadi Kokabi, Hassan Dianat-Moghadam, Mohammad Mehrmohammadien Limba Engleză Paperback – dec 2021
Although considerable efforts have been conducted to diagnose, improve and treat cancer in the past few decades, existing therapeutic options are insufficient, as mortality and morbidity rates remain high. One of the best hopes for substantial improvement lies in early detection. Recent advances in nanotechnology are expected to increase our current understanding of tumor biology, allowing nanomaterials to be used for targeting and imaging both in vitro and in vivo experimental models.
- Gives understanding of cancer biology that is appropriate for students and researchers in engineering and nanotechnology
- Demonstrates cancer targeting strategies of multifunctional nanotechnology-based imaging probes
- Shows how to design, synthesize and apply cancer imaging nanostructures
Preț: 640.33 lei
Preț vechi: 703.65 lei
-9%
Puncte Express: 960
Carte tipărită la comandă
Livrare economică 07-21 septembrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780128245132
ISBN-10: 0128245131
Pagini: 216
Ilustrații: 55 illustrations (20 in full color)
Dimensiuni: 152 x 229 x 19 mm
Greutate: 0.3 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128245131
Pagini: 216
Ilustrații: 55 illustrations (20 in full color)
Dimensiuni: 152 x 229 x 19 mm
Greutate: 0.3 kg
Editura: ELSEVIER SCIENCE
Public țintă
Reseachers and students in diagnostic imaging, nanomedicine technology, biotechnology, biomedical engineering, cancer biology, molecular biology, epigenetics, oncology.Cuprins
1. Introduction
2. Passive Targeting
3. Active targeting
4. Tumor-Specific Imaging Probes in Clinical Trials
5. Challenges and Future Directions
2. Passive Targeting
3. Active targeting
4. Tumor-Specific Imaging Probes in Clinical Trials
5. Challenges and Future Directions